Raquel
Marzoa Rivas
University Hospital Bratislava
Bratislava, EslovaquiaPublications in collaboration with researchers from University Hospital Bratislava (1)
2019
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397